The avidity of anti-beta2-glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies.

@article{unik2011TheAO,
  title={The avidity of anti-beta2-glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies.},
  author={Sa{\vs}a {\vC}u{\vc}nik and Tanja Kveder and Zdenka Ulcov{\'a}-Gallov{\'a} and Jakub Swadźba and Jacek Musial and Guido Valesini and Tadej Av{\vc}in and Bla{\vz} Rozman and Borut Bo{\vz}i{\vc}},
  journal={Lupus},
  year={2011},
  volume={20 11},
  pages={1166-71}
}
OBJECTIVE The objective of this study was to extend the findings of the preliminary study by measuring the avidity of IgG anti-β2-glycoprotein I antibodies (anti-β2-GPI) on a larger group of patients with primary or secondary antiphospholipid syndrome (APS) and anti-β2-GPI positive patients without APS in the frame of the European Forum on antiphospholipid antibodies (aPL). METHODS Serum from 137 patients with primary APS, APS associated with autoimmune diseases, and patients with autoimmune… CONTINUE READING